Since his enrolment in Osborne Clarke in 2015, Gustavo has developed expertise in anti-corruption compliance and commercial agreements, particularly within the pharmaceutical sector.
Gustavo focuses his career within the life science and healthcare field, advising top pharmaceutical companies in all commercial-related matters.
He also counsels a global leader group devoted to blood plasma products in the development and follow-up of anti-corruption compliance obligations.
Grifols, S.A.
Development of compliance program within Grifols affiliates worldwide.
Fundación Probitas
Advised on Project Yakaar, which provides socio-labour inclusion to young Senegalese in Barcelona.
Insights
New compliance challenges for large companies: analysis of the Directive on corporate sustainability due diligence
Health ministry initiates Spain's regulatory approval of cannabis for medicinal and therapeutic use
Introduction to Directive (EU) 2019/1937
The European Parliament and the Council of the European Union approve the Directive for the harmonisation of the protection of...
MedTech Europe Code of Ethical Business Practice and its implementation at European level
MedTech Europe establishes a 2020 roadmap for member companies and national associations to adopt the standards established in its code...